< Back to Jobs

Intern, Asset Acquisition


BridgeBio / GondolaBio

Multiple | Remote/Flexible

Posted January 22

Job Description


Intern, Asset Acquisition, GondolaBio

About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

About BridgeBio

BridgeBio is a commercial stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company built a portfolio of 22+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, pulmonology, renal disease, and genetic dermatology, with three approved drugs. We have U.S. offices in San Francisco, Palo Alto, and Raleigh. We also have international offices in Montreal, Canada, and Switzerland.

Who You Are

GondolaBio’s Asset Acquisition team is seeking an Intern to help us define our new programs. We are looking for ambitious scientists who’d like to contribute at the intersection of science and business. This team member will stay abreast of the latest publications and conferences and communicate key findings to the discovery team and scientific leadership. This is a great opportunity to utilize your scientific background and training, while gaining experience in key aspects of drug development-- from genetic rationale and pre-clinical evidence all the way to the development plan and clinical trial design.

The Asset Acquisition team is responsible for finding, evaluating, and determining which therapeutic ideas GondolaBio will pursue, with an emphasis on evaluation of the scientific rationale behind therapeutic strategies. The team works closely with GondolaBio’s Investment Committee, which is composed of veteran drug developers and renowned academic scientists. Across the BridgeBio ecosystem, we have spearheaded partnerships with academic and industry groups to create, fund, and operate >30 new drug development programs.

Interested candidates should apply by submitting a resume or academic-style CV and a short (<1 page) cover letter. 

Essential Skills and Function

Preferred Education and Experience

 No matter your role, successful team members are:

What We Offer



Invite Friends To Join Doc